PT Sarana Menara (TOWR)
Indonesia Stock Exchange · Indonesia · prices in IDR · close of 27 Oct 2026
Key indicators
| Last close | IDR 400.00 |
|---|---|
| 52-week range | 310.00 – 650.00 |
| Return, 1 month / 3 months | +2.6% / −1.5% |
| Return, 1 year / 3 years | −21.4% / −47.1% |
| Trend | Below its 200-day average |
| RSI (14) | 44 |
| Volatility (1 year) | 41.6% |
| Worst drawdown (1 year) | -48.5% |
| Average daily value traded | 33,847.84M IDR |
| Dividend yield | 3.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
PT Sarana Menara Nusantara builds and operates telecommunications towers in Indonesia. The company leases space on its towers to mobile network operators, which install their antennas and transmission equipment there to provide wireless coverage. Its customers are telecom carriers serving consumers and businesses across the country. The company is based in Indonesia and works with operators on tower construction, site management and related infrastructure services that support mobile networks.
PT Sarana Menara trades under the code TOWR on the Indonesia Stock Exchange in Indonesia, with its price quoted in Indonesian rupiah (IDR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
PT Sarana Menara (TOWR) trades on the Indonesia Stock Exchange in Indonesia. It last closed at IDR 400.00 on 27 October 2026.
Its price-based Market X-Ray is 64 out of 100 (a fair price profile), ranking 254 of 923 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 21.4% and over the last three months it fell 1.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Indonesia Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 58 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -9.7% | ||
| From 52-week high | -36.0% | ||
| Momentum | 47 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -1.5% | ||
| 6-month return | -15.5% | ||
| 12-month return, skipping the last month | -23.4% | ||
| Stability (higher is calmer) | 65 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 41.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -48.5% | ||
| Liquidity | 92 · Strong | Trades actively. | |
| Average daily value traded | 33,847.84M IDR | ||
| Zero-volume days | 3.3% | ||
| Income | 73 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 3.4% | ||
| Years with dividends | 6 |
Strengths
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +3.1% |
|---|---|
| 1 month | +2.6% |
| 3 months | −1.5% |
| 6 months | −15.5% |
| 1 year | −21.4% |
| 3 years | −47.1% |
| 5 years | −60.2% |
Signals
| 50-day / 200-day average | 430.44 / 443.05 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | Yes |
| Average daily range (ATR) | 23.18 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 3 Jun 2026 | IDR 6.8900 |
| 10 Dec 2025 | IDR 6.8700 |
| 5 May 2025 | IDR 9.9000 |
| 7 Jan 2025 | IDR 6.0000 |
| 5 Jul 2024 | IDR 18.1000 |
| 15 Dec 2023 | IDR 6.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Indonesia Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.